Paxman Summit and Product Communications Blog

By Patricia Thangaraj

Oncologists, general practitioners, radiation therapists, other clinicians, scientists, nurses and other health care professionals from across the globe are being invited to be a part of the inaugural Paxman Scalp Cooling Summit, scheduled to take place on May 5th, 2022.

This Summit presents an opportunity for those in the medical community to share their knowledge, ideas and best practices as well as generate feedback on precision side effect management, thereby creating an avenue for these practitioners to advance the future of supportive cancer care and scalp cooling.

Hosted virtually, the Summit would facilitate various talks, key note discussions and live dialogue so that participants can see the benefits of scalp cooling in individual system management as well as the knowledge necessary to execute better scalp cooling mechanisms in their respective clinical practices.

One of the objectives of the Summit is to transcend side effect management in cancer care. It is with this in mind that pioneers would be invited to explore new concepts in relation to disseminating excellent patient care in their practices.

There are no requirement to become a Summit delegate, only a genuine desire to learn more about scalp cooling and how this medical device can enhance patient centric care in oncology and precision side effect management.

The Summit therefore presents an excellent opportunity for global health care practitioners to build relationships with fellow health care providers in knowledge enhancement.

Some of the Keynote Sessions include:

13:00 – 14:00 Beyond Hair Retention – Scalp Cooling for Regrowth

17:00 – 18:00 Development of the Chemotherapy-Induced Peripheral Neuropathy Cryocompression Device

20:15 – 21:15 Beyond Hair Retention – Scalp Cooling for Regrowth

01:15 – 02:15 The Psychosocial Impact of Chemotherapy Side Effects – During Treatment and Beyond

Meanwhile, Roundtable Sessions include:

10:15 – 11:15 Patient-Centred Care – Beyond the Buzzword

12:45 – 14:15 What Next? The Future of Scalp Cooling Trials and Research

14:30 – 15:30 Chemotherapy Side Effect Management for Patients of Color – Why Equity Matters in Cancer Care

17:00 – 18:00 The Importance of Protocols in Achieving Efficacious Scalp Cooling (Keynote)

20:15 – 21:45 What Next? The Future of Scalp Cooling Trials and Research

00:00 – 01:00 The Importance of Protocols in Achieving Efficacious Scalp Cooling (Keynote)

01:15 – 02:15 Patient-Centred Care – Beyond the Buzzword

How it Works

It is not cancer that causes hair loss. It is the chemotherapy used to treat cancer that causes the hair loss or alopecia. This is because chemotherapy targets all rapidly dividing cells in the body and since hair is the second fastest dividing cell, it is automatically impacted, resulting in alopecia.

One of the ways that scalp cooling aims to combat this issue to reduce the effects that chemotherapy drugs can have on hair follicles by reducing the temperature on the scalp before, during and after chemotherapy is administered. This results in a decrease of blood flow to the hair follicles, which may prevent or minimize hair loss.

Click here to learn more: https://www.youtube.com/watch?v=IhbpQbN5BXs

Safety Considerations

Clinical studies have shown the effectiveness of the Paxman Scalp Cooling System in preventing alopecia brought on by chemotherapy drugs for breast cancer patients. However, the success rate of hair retention varies from patient to patient. Some of the clinical factors to consider include chemotherapy dosage and regimens, the duration of drug infusion, the metabolic rate of the chemotherapy drugs and concomitant comorbidities among other things.

Meanwhile, a patient’s age, hair type, the condition of their hair and their overall health are some of the non-clinical factors that can affect the success levels of the Paxman Scalp Cooling System. Therefore, there is no guarantee that scalp cooling can ensure that all patients undergoing chemotherapy retain all or some of their hair.

However, research has proven that scalp cooling is very effective across a wide range of chemotherapy regimens. Patients may experience some hair loss or thinning during scalp cooling as the normal hair shedding cycle will take place. However, they are encouraged to continue with scalp cooling because many women have reported hair growth during their chemotherapy treatment.

Does Scalp Cooling Work?

Many women and men from across the globe have kept their hair while using the Paxman Scalp Cooling System during chemotherapy treatment.  

Who can use the Paxman Scalp Cooling System?

The Paxman Scalp Cooler has been shown to reduce the likelihood of chemotherapy-induced alopecia (CIA) in patients who have solid tumour cancers.

References:

https://scalpcoolingsummit.com/

#Paxman #events #medicaldevices #productcommunications